INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 438m ago
HOUSE PTR38m ago
SEC 13F38m ago
ROBINHOOD CHAIN37m ago
Corporate insider
HC

Hite Christopher

EVP & Vice ChairmanCIK 0001814238

EDGAR filingsOpen in network
Disclosed transactions9
Buys / sells0 / 5
Max Insider Score23
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
23
HC
Hite ChristopherEVP & Chairman, Partnering
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$5.62M
96.1K sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Royalty Pharma plcEVP & Vice Chairman · Nov 7, 2025
9
HC
Hite ChristopherEVP & Chairman, Partnering
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL
$231K
3,927 sh
Sep 22, 2026
Sep 24, 2026
traded Sep 22, 2026
+2d
SEC FORM 4

Evidence

10
HC
Hite ChristopherEVP & Chairman, Partnering
RPRXRoyalty Pharma plc
Gift · 10b5-1 plan
G—
16.8K sh
Aug 19, 2026Aug 19, 2026
traded Aug 19, 2026
+0dSEC FORM 4

Evidence

23
HC
Hite ChristopherEVP & Chairman, Partnering
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$6.00M
100.0K sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC FORM 4

Evidence

5
HC
Hite ChristopherEVP & Chairman, Partnering
RPRXRoyalty Pharma plc
Grant or award
A—
11.0K sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC FORM 4

Evidence

23
HC
Hite ChristopherEVP & Chairman, Partnering
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$6.41M
117.6K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

19
HC
Hite ChristopherEVP & Chairman, Partnering
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$1.75M
32.4K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

9
HC
Hite ChristopherEVP & Vice Chairman
RPRXRoyalty Pharma plc
Grant or award
A—
26.6K sh
Feb 11, 2026Feb 13, 2026
traded Feb 11, 2026
+2dSEC FORM 4

Evidence

9
HC
Hite ChristopherEVP & Vice Chairman
RPRXRoyalty Pharma plc
Grant or award
A—
6,168 sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC FORM 4

Evidence